Stella Okoli, founder of Emzor Pharmaceutical Industries Ltd, is stepping back from the Nigerian drugmaker’s day-to-day management, with Pharm. Uzoma Ezeoke taking over as managing director as the company enters a new phase of leadership.

Stella Okoli, who established the business in Lagos in 1977 with a small chemist’s shop, remains the company’s founder and chief executive officer. Her transition marks a shift in operational responsibility after nearly five decades spent building Emzor into a major local pharmaceutical manufacturer with more than 140 products and an established presence in Nigeria’s healthcare sector.

From a chemist’s shop to a major pharmaceutical business

Okoli began her entrepreneurial journey in 1977, when she opened a small chemist’s shop in Lagos. Over the decades, that modest operation grew into Emzor Pharmaceutical Industries, a Nigerian drugmaker serving a sector central to healthcare delivery.

The company’s development reflects Okoli’s ambition to strengthen local pharmaceutical manufacturing in a country where access to essential medicines and domestic production capacity remain important healthcare priorities.

Beyond expanding its product portfolio, Emzor has contributed to Nigeria’s pharmaceutical ecosystem through local manufacturing, employment creation and talent development. Its growth also illustrates how homegrown businesses can help build industrial capacity in sectors traditionally reliant on imported products and inputs.

Local production remains a central ambition

A key part of Okoli’s legacy is her pursuit of greater pharmaceutical self-reliance in Nigeria. She has also pursued the ambition of producing active pharmaceutical ingredients locally, an objective linked to expanding domestic manufacturing capacity and reducing dependence on imported pharmaceutical inputs.

Emzor’s portfolio of more than 140 products underscores the scale of the business built since its establishment. Its presence in the healthcare industry places the company within broader efforts to strengthen the country’s ability to manufacture medicines and support its healthcare supply chain.

For Okoli, the company’s growth represents more than the expansion of a private business. It reflects a long-standing industrial ambition to build local capacity in a sector where domestic production can play an important role in meeting essential needs.

Uzoma Ezeoke takes over daily management

Ezeoke’s appointment as managing director places him in charge of Emzor’s day-to-day operations as the company moves into its next stage of development. The transition shifts operational responsibility while Okoli retains her position as founder and chief executive officer.

Her continued role means the change is not a complete exit from the business. Instead, it separates daily management from the founder’s continuing executive position, providing a new leadership structure for the company.

The available announcement does not specify the timeline for the transition or outline any changes to Emzor’s strategic priorities under Ezeoke.

A legacy of pharmaceutical self-reliance

Okoli’s journey from a small Lagos chemist’s shop to the founder and CEO of a major Nigerian pharmaceutical manufacturer highlights the resilience and long-term commitment required to build an industrial enterprise.

As Ezeoke assumes day-to-day management, the challenge will be to build on the manufacturing capacity, product portfolio and market presence developed under Okoli’s leadership.

After nearly 50 years in the pharmaceutical industry, Stella Okoli’s transition marks a new chapter for Emzor, with its next phase resting on the foundations of a business built around local production and Nigeria’s healthcare needs.